Shanghai Henlius Biotech (HKG:2696) said its investigational new drug application for a Phase I clinical trial of HLX37 in combination with chemotherapy or HLX43 has been approved by China's National Medical Products Administration.
HLX37, a bispecific antibody targeting PD-L1 and VEGF, is being evaluated for the treatment of advanced or metastatic solid tumors, according to a Hong Kong bourse filing. The company plans to begin the trial in mainland China once the required conditions are met.
FDC Consolidated Holdings (ASX:FDC) shares rose nearly 4% in recent Friday trade on the construction firm's second day of trading on the Australian bourse.The company raised AU$400.8 million in its initial public offering through the issue of about 133.6 million shares at a price of AU$3 each.
Indian technology giant Tata Consultancy Services (NSE:TCS, BOM:532540) does not plan to reduce its overall headcount due to artificial intelligence (AI) and will hire for newer AI-native skill sets, according to a Moneycontrol.com report on Thursday, citing the company's chief executive officer and managing director K Krithivasan.Krithivasan's comments come amid rising concerns of job losses due to the notion that AI will replace employees.There would be no "drastic change" in headcount, however, there could be a change in the skillset requirements, and other new opportunities would come up, Krithivasan said at the company's June earnings conference on Thursday, according to the news report.In the fiscal first quarter ended June 30, Tata Consultancy Services recorded its biggest quarterly headcount addition in four years with the addition of 9,279 employees on a net basis, taking its total workforce to 593,798, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
(Update to add stock movement in the headline and the sixth paragraph)Sandfire Resources (ASX:SFR) issued an updated pre-feasibility study (PFS) for its Black Butte copper project in Montana, outlining a substantially larger development with an extended mine life and enhanced project scale, according to an Australian bourse filing on Thursday after market hours.The study reports a maiden ore reserve for the Lowry deposit of 4.7 million tonnes grading 2.1% copper, containing 100,000 tonnes of copper, alongside a 255% increase in the Lowry mineral resource to 31.5 million tonnes grading 1.3% copper, containing 400,000 tonnes of copper, per the filing.Additionally, Black Butte's total ore reserves increased by 49% to 14.3 million tonnes grading 2.6% copper, containing 370,000 tonnes of copper, extending the planned mine life by about 50% to 12 years, the filing said.The project is expected to produce 35,000 tonnes per annum of contained copper in its first four years, averaging 31,000 tonnes per annum over the initial mine life, with Johnny Lee fully permitted and Lowry advancing through approvals.The PFS is based on a long-term copper price of $4.70 per pound, with initial capital expenditure estimated at around $474 million, life-of-mine sustaining capital of $180 million, an 88% metallurgical recovery rate, and a C1 cash cost of $2.68 per pound of payable copper, the filing added.Its shares rose 4% in recent trading on Friday.